FemtoDx Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12M
- Investors
-
4
FemtoDx General Information
Description
Developer of monitoring markers designed to monitor heart failure and stroke at home. The company's markers are used for home-based monitoring of cardiovascular diseases with a panel of clinically validated biomarkers through a multiplexed molecular diagnosis at clinically relevant levels and at a fraction of the cost and time, enabling heart patients to detect heart failure and ischemic strokes.
Contact Information
Website
www.femtodx.comCorporate Office
- 8929 Wilshire Boulevard
- Suite 320
- Beverly Hills, CA 90211
- United States
Corporate Office
- 8929 Wilshire Boulevard
- Suite 320
- Beverly Hills, CA 90211
- United States
FemtoDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 09-Jul-2019 | $12M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue |
FemtoDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
FemtoDx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
FemtoDx Patents
FemtoDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230149928-A1 | Sensor-based systems and methods for diagnostic and field use detection of nucleic acids | Pending | 03-Apr-2020 | ||
| US-20210263025-A1 | Micro-separation for multiplexing | Pending | 20-Feb-2020 | ||
| EP-4096829-A1 | Fluidic stack and reference electrode for sample collection and analysis and related methods | Pending | 27-Jan-2020 | ||
| EP-4096829-A4 | Fluidic stack and reference electrode for sample collection and analysis and related methods | Pending | 27-Jan-2020 | ||
| US-20210255140-A1 | Fluidic stack and reference electrode for sample collection and analysis and related methods | Inactive | 27-Jan-2020 | B01L3/502753 |
FemtoDx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
FemtoDx Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canon Medical Systems | Corporation | Minority | ||
| K2X | Venture Capital | Minority | ||
| Next Orbit Ventures | Growth/Expansion | Minority | ||
| Magnify | Accelerator/Incubator |
FemtoDx FAQs
-
When was FemtoDx founded?
FemtoDx was founded in 2014.
-
Where is FemtoDx headquartered?
FemtoDx is headquartered in Beverly Hills, CA.
-
What is the size of FemtoDx?
FemtoDx has 9 total employees.
-
What industry is FemtoDx in?
FemtoDx’s primary industry is Monitoring Equipment.
-
Is FemtoDx a private or public company?
FemtoDx is a Private company.
-
What is the current valuation of FemtoDx?
The current valuation of FemtoDx is .
-
What is FemtoDx’s current revenue?
The current revenue for FemtoDx is .
-
How much funding has FemtoDx raised over time?
FemtoDx has raised $12M.
-
Who are FemtoDx’s investors?
Canon Medical Systems, K2X, Next Orbit Ventures, and Magnify have invested in FemtoDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
